2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC5276
  



  

  
Submitter : 
  

  
Ms. Jessenia Figueroa
  

  
Date & Time: 
  

  
12/29/2006 08:12:29
  



  

  
Organization : 
  

  
BioClarity 
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Regarding FDA guidelines, Docket Number 2006D-0383, I am frustrated that there arent any hepatitis A, rubella, or varicella vaccines, which origins do not come from tissue of aborted fetuses. My 13-month-old baby will not be able to obtain these vaccines because I cannot morally condone something obtained in such a corrupt manner. In addition to this, it is difficult to obtain measles and mumps vaccines without the common combo of measles, mumps, and rubella. Many medical establishments do not offer these vaccines individually and this includes the publicly funded Clark County Health Department. I ask that the FDA review pharmaceutical companies in Europe or elsewhere for the possible approval of alternatively produced vaccines. Also, consumers of vaccines today should be educated by the health professional on the origins of their vaccine before it is administered to them.